J Rheum Dis.  2023 Oct;30(4):209-210. 10.4078/jrd.2023.0047.

Administrative regional variation in cardiovascular risk among patients with gout: implications for the management of cardiovascular complications

• Choi ST

• KMID: 2546236
• DOI: http://doi.org/10.4078/jrd.2023.0047

Reference

1. Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH. 2017; Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol Int. 37:1499–506. DOI: 10.1007/s00296-017-3768-4. PMID: 28676911.

2. Jeong YJ, Park S, Yon DK, Lee SW, Tizaoui K, Koyanagi A, et al. 2023; Global burden of gout in 1990-2019: a systematic analysis of the Global Burden of Disease study 2019. Eur J Clin Invest. 53:e13937. DOI: 10.1111/eci.13937. PMID: 36511834.

3. Kuo CF, Grainge MJ, Zhang W, Doherty M. 2015; Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 11:649–62. DOI: 10.1038/nrrheum.2015.91. PMID: 26150127.

4. Abeles AM, Pillinger MH. 2019; Gout and cardiovascular disease: crystallized confusion. Curr Opin Rheumatol. 31:118–24. DOI: 10.1097/BOR.0000000000000585. PMID: 30601229.

5. Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT. 2021; Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol. 3:e58–70. DOI: 10.1016/S2665-9913(20)30221-6. PMID: 32904897. PMCID: PMC7462628.

6. Flora GD, Nayak MK. 2019; A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des. 25:4063–84. DOI: 10.2174/1381612825666190925163827. PMID: 31553287.

7. Disveld IJM, Fransen J, Rongen GA, Kienhorst LBE, Zoakman S, Janssens HJEM, et al. 2018; Crystal-proven gout and characteristic gout severity factors are associated with cardiovascular disease. J Rheumatol. 45:858–63. DOI: 10.3899/jrheum.170555. PMID: 29657151.

8. Moon KW, Kim MJ, Choi IA, Shin K. 2022; Cardiovascular risks in Korean patients with gout: analysis using a National Health Insurance Service database. J Clin Med. 11:2124. DOI: 10.3390/jcm11082124. PMID: 35456221. PMCID: PMC9030984.

9. Singh GK, Siahpush M. 2014; Widening rural-urban disparities in all-cause mortality and mortality from major causes of death in the USA, 1969-2009. J Urban Health. 91:272–92. DOI: 10.1007/s11524-013-9847-2. PMID: 24366854. PMCID: PMC3978153.

10. Kim HJ, Ghang B, Kim J, Ahn HS. 2023; Regional variations of cardiovascular risk in gout patients: a nationwide cohort study in Korea. J Rheum Dis. 30:185–97. DOI: 10.4078/jrd.2023.0011. PMID: 37476678. PMCID: PMC10351371.

11. Abrams LR, Myrskylä M, Mehta NK. 2022; The growing rural-urban divide in US life expectancy: contribution of cardiovascular disease and other major causes of death. Int J Epidemiol. 50:1970–8. DOI: 10.1093/ije/dyab158. PMID: 34999859. PMCID: PMC8743112.

12. White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, et al. 2018; Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 378:1200–10. DOI: 10.1056/NEJMoa1710895. PMID: 29527974.